September 21, 2007 — Cianna Medical has been created as a new company to focus exclusively on its innovative SAVI breast brachytherapy technology.
Cianna is a spinoff of BioLucent Inc., with Cianna retaining the same team that developed the SAVI technology.
The creation of Cianna Medical comes with the completion of Hologic Inc.'s acquisition of BioLucent and its MammoPad breast cushion business. Virtually all of BioLucent's leadership team will remain at Cianna Medical.
SAVI offers women who have had lumpectomy surgery a more convenient, five-day course of treatment than is available with external radiation. The standard course of treatment for external radiation is six to seven weeks and can create a significant disruption in the lives of women and their families.
In addition to a shorter course of treatment, the multi-catheter, expandable SAVI applicator provides a precisely targeted, contoured dose of radiation that treats tissue surrounding the lumpectomy cavity from the inside out.
This approach is designed to make the benefits of partial breast irradiation available to a larger group of women. It also gives more treatment planning flexibility to the radiation oncologist and physicist, and gives physicians the ability to control and contour the radiation dose.
For more information: www.ciannamedical.com